An approach to treat conundrumof skin cancer: Bioactive loaded Niosomes

IF 0.3 Q4 PHARMACOLOGY & PHARMACY
S. Srivastava, D. Sharma
{"title":"An approach to treat conundrumof skin cancer: Bioactive loaded Niosomes","authors":"S. Srivastava, D. Sharma","doi":"10.2174/1574885518666230209150126","DOIUrl":null,"url":null,"abstract":"\n\nSkin cancer is a life-threatening disease according to the World Health Organization, majorly affecting the white population. The major concerning factors that are responsible for skin cancer are genetic factors, environmental exposure including UV rays and pollutants. The UV radiations excessively generate Reactive oxygen species (ROS) and Reactive nitrogen species (RNS)due to which the oxidative stress mediates and alters numerous signaling pathways. Quercetin is a flavonoid that plays a vital role in protecting the cell from oxidative stressin addition to possessing anticancer, antioxidant, and anti-inflammatory properties. The present article focuses on the delivery of natural flavonoid quercetin via novel carrier noisome to enhance targeting and safety efficacy.\n\n\n\nThe risk of developing skin cancer arises from a combination of genetic and environmental factors, the most common cause being prolonged exposure to ultraviolet (UV) light. Quercetin is a flavanoid that plays a vital role in protecting cell from oxidative stress that are activated by reactive oxygen species. It has been hence proved that the reactive oxygen species (ROS) and reactive nitrogen species (RNS) forms on of the basic cause of cancer. The drug carrier noisome enhances the bioavailability of the natural products and have an advantage of solubilizing the lipophilic compound and prevent them from deuteriation into “antagonist” condition in human blood.\n\n\n\nThus, current research work focuses over designing and characterization of niosomes system for the treatment of skin cancer and target oxidative stress. Though many novel drug deliveries have been designed as carrier system in skin cancer, among all niosomes have been found as potential colloidal carrier.\n\n\n\nQuercetin loaded niosomes were developed and was optimized, characterized for morphological studies, entrapment efficiency, zeta potential and In vitro drug release.\n\n\n\nThe quercetin loaded niosomal vesicles under the transmission electron microscope were found in range of 120 nm with suitable zeta potential and entrapment efficiency above 80% with control release profile.\n\n\n\nFormulation was successfully prepared which can be further carried out for in vivo studies.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574885518666230209150126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Skin cancer is a life-threatening disease according to the World Health Organization, majorly affecting the white population. The major concerning factors that are responsible for skin cancer are genetic factors, environmental exposure including UV rays and pollutants. The UV radiations excessively generate Reactive oxygen species (ROS) and Reactive nitrogen species (RNS)due to which the oxidative stress mediates and alters numerous signaling pathways. Quercetin is a flavonoid that plays a vital role in protecting the cell from oxidative stressin addition to possessing anticancer, antioxidant, and anti-inflammatory properties. The present article focuses on the delivery of natural flavonoid quercetin via novel carrier noisome to enhance targeting and safety efficacy. The risk of developing skin cancer arises from a combination of genetic and environmental factors, the most common cause being prolonged exposure to ultraviolet (UV) light. Quercetin is a flavanoid that plays a vital role in protecting cell from oxidative stress that are activated by reactive oxygen species. It has been hence proved that the reactive oxygen species (ROS) and reactive nitrogen species (RNS) forms on of the basic cause of cancer. The drug carrier noisome enhances the bioavailability of the natural products and have an advantage of solubilizing the lipophilic compound and prevent them from deuteriation into “antagonist” condition in human blood. Thus, current research work focuses over designing and characterization of niosomes system for the treatment of skin cancer and target oxidative stress. Though many novel drug deliveries have been designed as carrier system in skin cancer, among all niosomes have been found as potential colloidal carrier. Quercetin loaded niosomes were developed and was optimized, characterized for morphological studies, entrapment efficiency, zeta potential and In vitro drug release. The quercetin loaded niosomal vesicles under the transmission electron microscope were found in range of 120 nm with suitable zeta potential and entrapment efficiency above 80% with control release profile. Formulation was successfully prepared which can be further carried out for in vivo studies.
一种治疗皮肤癌难题的方法:生物活性载体
据世界卫生组织称,皮肤癌是一种危及生命的疾病,主要影响白人。导致皮肤癌的主要因素是遗传因素、环境暴露,包括紫外线和污染物。紫外线辐射过量产生活性氧(ROS)和活性氮(RNS),因此氧化应激介导和改变了许多信号通路。槲皮素是一种类黄酮,除了具有抗癌、抗氧化和抗炎的特性外,还在保护细胞免受氧化应激方面起着至关重要的作用。本文主要研究天然类黄酮槲皮素通过新型载体载体的传递,以提高靶向性和安全性。患皮肤癌的风险是由遗传和环境因素共同引起的,最常见的原因是长时间暴露在紫外线下。槲皮素是一种黄酮类化合物,在保护细胞免受活性氧激活的氧化应激中起着至关重要的作用。由此证明,活性氧(ROS)和活性氮(RNS)是形成癌症的基本原因之一。该药物载体提高了天然产物的生物利用度,具有溶解亲脂性化合物,防止其在人体血液中氘化为“拮抗剂”的优点。因此,目前的研究工作主要集中在设计和表征用于治疗皮肤癌和靶向氧化应激的纳米体系统。虽然许多新的药物递送被设计为皮肤癌的载体系统,但在所有的乳质体中都发现了潜在的胶体载体。制备并优化了槲皮素负载niosomes,并对其进行了形态学、包封效率、zeta电位和体外释药特性研究。在透射电镜下,槲皮素负载的乳质体囊泡在120 nm范围内具有合适的zeta电位,包封效率在80%以上,并具有控释轮廓。制剂制备成功,可进一步进行体内研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信